Concurrent Veliparib With Chest Wall and Nodal Radiotherapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter Study

PURPOSE: Locoregional control for inflammatory breast cancers and chest wall recurrences is suboptimal, which has motivated interest in radiosensitization to intensify therapy. Preclinical studies have suggested a favorable therapeutic index when poly (ADP-ribose) polymerase inhibitors are used as r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Autores principales: Jagsi, Reshma, Griffith, Kent A., Bellon, Jennifer R., Woodward, Wendy A., Horton, Janet K., Ho, Alice, Feng, Felix Y., Speers, Corey, Overmoyer, Beth, Sabel, Michael, Schott, Anne F., Pierce, Lori
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society of Clinical Oncology 2018
Materias:
ORIGINAL REPORTS
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6804907/
https://ncbi.nlm.nih.gov/pubmed/29558281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.77.2665
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares